Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: February 21, 2026, 11:46 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 500459 | NSE: PGHH

Procter & Gamble Hygiene and Health Care Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: February 21, 2026, 11:46 am

Market Cap 37,333 Cr.
Current Price 11,501
Intrinsic Value₹8,293.52
High / Low 14,543/11,312
Stock P/E43.4
Book Value 287
Dividend Yield1.48 %
ROCE104 %
ROE75.7 %
Face Value 10.0
PEG Ratio5.20

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Procter & Gamble Hygiene and Health Care Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Honasa Consumer Ltd 9,787 Cr. 301 334/19063.3 38.80.00 %7.44 %5.51 % 10.0
Ambica Agarbathies Aroma & Industries Ltd 43.0 Cr. 25.0 33.0/22.362.3 65.20.00 %7.49 %0.45 % 10.0
Ador Multi Products Ltd 112 Cr. 117 149/23.5 32.50.00 %11.4 %3.09 % 10.0
Kaya Ltd 501 Cr. 330 488/204 60.90.00 %2.50 %% 10.0
Jyothy Labs Ltd 9,035 Cr. 246 400/23724.7 55.81.42 %24.6 %19.0 % 1.00
Industry Average69,563.86 Cr1,845.2451.87112.700.86%29.21%23.91%4.94

All Competitor Stocks of Procter & Gamble Hygiene and Health Care Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 1,1378838531,1381,1331,0029321,1351,2489929371,1501,262
Expenses 847734638853824745813845877782671865860
Operating Profit 290149215285310257118290371210266285402
OPM % 26%17%25%25%27%26%13%26%30%21%28%25%32%
Other Income 9141016161478101981012
Interest 4432322-0276043
Depreciation 141515141415131210109910
Profit before tax 282146207284309234112285364213265282402
Tax % 26%-13%27%26%26%34%28%26%26%27%27%26%25%
Net Profit 20716515121122915481212269156192210301
EPS in Rs 63.9150.8446.5964.9170.5247.5624.9765.2882.7448.0959.1764.6592.87

Last Updated: February 7, 2026, 12:03 am

Below is a detailed analysis of the quarterly data for Procter & Gamble Hygiene and Health Care Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:

  • For Sales, as of Dec 2025, the value is 1,262.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,150.00 Cr. (Sep 2025) to 1,262.00 Cr., marking an increase of 112.00 Cr..
  • For Expenses, as of Dec 2025, the value is 860.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 865.00 Cr. (Sep 2025) to 860.00 Cr., marking a decrease of 5.00 Cr..
  • For Operating Profit, as of Dec 2025, the value is 402.00 Cr.. The value appears strong and on an upward trend. It has increased from 285.00 Cr. (Sep 2025) to 402.00 Cr., marking an increase of 117.00 Cr..
  • For OPM %, as of Dec 2025, the value is 32.00%. The value appears strong and on an upward trend. It has increased from 25.00% (Sep 2025) to 32.00%, marking an increase of 7.00%.
  • For Other Income, as of Dec 2025, the value is 12.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Sep 2025) to 12.00 Cr., marking an increase of 2.00 Cr..
  • For Interest, as of Dec 2025, the value is 3.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.00 Cr. (Sep 2025) to 3.00 Cr., marking a decrease of 1.00 Cr..
  • For Depreciation, as of Dec 2025, the value is 10.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9.00 Cr. (Sep 2025) to 10.00 Cr., marking an increase of 1.00 Cr..
  • For Profit before tax, as of Dec 2025, the value is 402.00 Cr.. The value appears strong and on an upward trend. It has increased from 282.00 Cr. (Sep 2025) to 402.00 Cr., marking an increase of 120.00 Cr..
  • For Tax %, as of Dec 2025, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 26.00% (Sep 2025) to 25.00%, marking a decrease of 1.00%.
  • For Net Profit, as of Dec 2025, the value is 301.00 Cr.. The value appears strong and on an upward trend. It has increased from 210.00 Cr. (Sep 2025) to 301.00 Cr., marking an increase of 91.00 Cr..
  • For EPS in Rs, as of Dec 2025, the value is 92.87. The value appears strong and on an upward trend. It has increased from 64.65 (Sep 2025) to 92.87, marking an increase of 28.22.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 18, 2026, 11:51 am

MetricJun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025n n 9mTTM
Sales 2,0512,3342,2752,3202,4552,9473,0023,5743,9013,9184,2063,3744,341
Expenses 1,6281,8381,6671,6461,8342,3292,3962,6883,0693,0483,2302,5033,178
Operating Profit 4234956086756226186068868328699768711,162
OPM % 21%21%27%29%25%21%20%25%21%22%23%26%27%
Other Income 78648567184542382340473749
Interest 5661055661111271412
Depreciation 35535260525048485358563238
Profit before tax 4605016366725826075948707908399398621,161
Tax % 34%31%34%36%36%31%27%25%27%19%28%26%
Net Profit 302346422433375419433652576678675637859
EPS in Rs 93.04106.63130.16133.31115.40129.12133.42200.79177.37208.91207.95196.11264.78
Dividend Payout % 30%28%28%292%35%68%79%157%90%89%123%89%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year
YoY Net Profit Growth (%)
Change in YoY Net Profit Growth (%)

No data available for trend analysis.

Growth

Compounded Sales Growth
10 Years:5%
5 Years:3%
3 Years:-2%
TTM:3%
Compounded Profit Growth
10 Years:8%
5 Years:8%
3 Years:-1%
TTM:23%
Stock Price CAGR
10 Years:8%
5 Years:6%
3 Years:-1%
1 Year:-16%
Return on Equity
10 Years:52%
5 Years:68%
3 Years:79%
Last Year:76%

Last Updated: September 4, 2025, 9:30 pm

Balance Sheet

Last Updated: December 4, 2025, 12:51 am

MonthJun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025Sep 2025
Equity Capital 32323232323232323232323232
Reserves 9701,1961,6194947738771,125682705914742705899
Borrowings 0000000354322
Other Liabilities 5057195156346207086719159401,1871,0811,0151,200
Total Liabilities 1,5081,9482,1661,1601,4251,6171,8281,6331,6832,1371,8591,7552,133
Fixed Assets 240309317286250234206184164170139131166
CWIP 98393541211522384423284114
Investments 0000000000000
Other Assets 1,1701,6001,8148341,1541,3681,6001,4111,4751,9451,6921,5831,953
Total Assets 1,5081,9482,1661,1601,4251,6171,8281,6331,6832,1371,8591,7552,133

Below is a detailed analysis of the balance sheet data for Procter & Gamble Hygiene and Health Care Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2025, the value is 32.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 32.00 Cr..
  • For Reserves, as of Sep 2025, the value is 899.00 Cr.. The value appears strong and on an upward trend. It has increased from 705.00 Cr. (Mar 2025) to 899.00 Cr., marking an increase of 194.00 Cr..
  • For Borrowings, as of Sep 2025, the value is 2.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
  • For Other Liabilities, as of Sep 2025, the value is 1,200.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,015.00 Cr. (Mar 2025) to 1,200.00 Cr., marking an increase of 185.00 Cr..
  • For Total Liabilities, as of Sep 2025, the value is 2,133.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,755.00 Cr. (Mar 2025) to 2,133.00 Cr., marking an increase of 378.00 Cr..
  • For Fixed Assets, as of Sep 2025, the value is 166.00 Cr.. The value appears strong and on an upward trend. It has increased from 131.00 Cr. (Mar 2025) to 166.00 Cr., marking an increase of 35.00 Cr..
  • For CWIP, as of Sep 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 41.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 27.00 Cr..
  • For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
  • For Other Assets, as of Sep 2025, the value is 1,953.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,583.00 Cr. (Mar 2025) to 1,953.00 Cr., marking an increase of 370.00 Cr..
  • For Total Assets, as of Sep 2025, the value is 2,133.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,755.00 Cr. (Mar 2025) to 2,133.00 Cr., marking an increase of 378.00 Cr..

Notably, the Reserves (899.00 Cr.) exceed the Borrowings (2.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthJun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025
Cash from Operating Activity + 335426352445415413474863573826470593
Cash from Investing Activity + -13528221149-1934757-27-101-34
Cash from Financing Activity + -95-105-122-1,559-106-314-190-1,106-569-477-861-666
Net Cash Flow 105349452-964290134358-236-23339-390-107

Free Cash Flow

MonthJun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025n n 9m
Free Cash Flow423.00495.00608.00675.00622.00618.00606.00883.00827.00865.00973.00871.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthJun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025
Debtor Days 151824212222201518202133
Inventory Days 534753714860687855485164
Days Payable 103148134145156162175237183213193235
Cash Conversion Cycle -35-83-57-53-87-79-87-144-110-145-121-138
Working Capital Days 4348-15-23-12-21-39-34-53-32-31
ROCE %52%46%45%64%89%73%58%94%110%101%112%104%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 70.64%70.64%70.64%70.64%70.64%70.64%70.64%70.64%70.64%70.64%70.64%70.64%
FIIs 1.05%1.13%1.30%1.48%1.57%1.56%1.48%1.43%1.33%1.38%1.11%1.06%
DIIs 15.44%15.49%15.45%15.29%15.11%15.16%15.28%15.37%15.50%15.49%16.05%16.03%
Public 12.87%12.73%12.61%12.60%12.67%12.65%12.60%12.56%12.52%12.48%12.19%12.25%
No. of Shareholders 39,96839,38837,06938,80739,99940,67142,34842,94144,87747,89149,99750,969

Shareholding Pattern Chart

No. of Shareholders

Procter & Gamble Hygiene and Health Care Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
SBI Focused Fund 900,000 2.7 1167.39N/AN/AN/A
ICICI Prudential Large Cap Fund 532,050 0.88 690.12N/AN/AN/A
SBI Equity Hybrid Fund 430,000 0.67 557.75430,0002025-04-22 15:16:470%
SBI Midcap Fund 280,000 1.56 363.19N/AN/AN/A
Sundaram Mid Cap Fund 97,729 0.95 126.7695,6912026-01-26 00:54:552.13%
Franklin India Mid Cap Fund 88,662 0.9 115N/AN/AN/A
Aditya Birla Sun Life MNC Fund 69,490 2.52 90.14N/AN/AN/A
UTI MNC Fund 49,185 2.23 63.838,0102025-12-08 02:04:5529.4%
Aditya Birla Sun Life Consumption Fund 38,899 0.77 50.46N/AN/AN/A
Sundaram Large and Mid Cap Fund 33,000 0.61 42.834,2362026-01-26 00:54:55-3.61%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Jun 24Jun 23Jun 22Jun 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 196.11207.95208.91177.37200.79
Diluted EPS (Rs.) 196.11207.95208.91177.37200.79
Cash EPS (Rs.) 205.96225.36226.89193.66215.48
Book Value[Excl.RevalReserv]/Share (Rs.) 227.04238.71291.44227.22220.05
Book Value[Incl.RevalReserv]/Share (Rs.) 227.04238.71291.44227.22220.05
Dividend / Share (Rs.) 175.00255.00185.00160.00315.00
Revenue From Operations / Share (Rs.) 1039.561295.661206.991201.761101.09
PBDIT / Share (Rs.) 279.85315.00280.10263.16284.55
PBIT / Share (Rs.) 270.01297.59262.12246.87269.87
PBT / Share (Rs.) 265.61289.34258.62243.42267.99
Net Profit / Share (Rs.) 196.12207.95208.91177.37200.80
PBDIT Margin (%) 26.9224.3123.2021.8925.84
PBIT Margin (%) 25.9722.9621.7120.5424.50
PBT Margin (%) 25.5422.3321.4220.2524.33
Net Profit Margin (%) 18.8616.0517.3014.7518.23
Return on Networth / Equity (%) 86.3787.1171.6878.0691.25
Return on Capital Employeed (%) 102.66110.0380.8597.31109.87
Return On Assets (%) 36.2736.3131.7234.2439.92
Asset Turnover Ratio (%) 1.872.112.052.352.07
Current Ratio (X) 1.231.221.381.321.34
Quick Ratio (X) 0.980.991.181.051.04
Inventory Turnover Ratio (X) 15.103.473.745.224.97
Dividend Payout Ratio (NP) (%) 104.53127.4369.4098.66169.32
Dividend Payout Ratio (CP) (%) 99.53117.5963.9090.36157.79
Earning Retention Ratio (%) -4.53-27.4330.601.34-69.32
Cash Earning Retention Ratio (%) 0.47-17.5936.109.64-57.79
Interest Coverage Ratio (X) 63.5238.1879.9076.34151.17
Interest Coverage Ratio (Post Tax) (X) 45.5226.2160.5952.45107.68
Enterprise Value (Cr.) 43676.2653361.7845454.0942869.0042606.67
EV / Net Operating Revenue (X) 12.9412.6911.6010.9911.92
EV / EBITDA (X) 48.0852.1949.9950.1946.13
MarketCap / Net Operating Revenue (X) 13.0912.8311.8511.1512.11
Retention Ratios (%) -4.53-27.4330.591.33-69.32
Price / BV (X) 59.9269.6349.0858.9960.58
Price / Net Operating Revenue (X) 13.0912.8311.8511.1512.11
EarningsYield 0.010.010.010.010.01

After reviewing the key financial ratios for Procter & Gamble Hygiene and Health Care Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Jun 24) which recorded 10.00.
  • For Basic EPS (Rs.), as of Mar 25, the value is 196.11. This value is within the healthy range. It has decreased from 207.95 (Jun 24) to 196.11, marking a decrease of 11.84.
  • For Diluted EPS (Rs.), as of Mar 25, the value is 196.11. This value is within the healthy range. It has decreased from 207.95 (Jun 24) to 196.11, marking a decrease of 11.84.
  • For Cash EPS (Rs.), as of Mar 25, the value is 205.96. This value is within the healthy range. It has decreased from 225.36 (Jun 24) to 205.96, marking a decrease of 19.40.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 227.04. It has decreased from 238.71 (Jun 24) to 227.04, marking a decrease of 11.67.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 227.04. It has decreased from 238.71 (Jun 24) to 227.04, marking a decrease of 11.67.
  • For Dividend / Share (Rs.), as of Mar 25, the value is 175.00. This value exceeds the healthy maximum of 3. It has decreased from 255.00 (Jun 24) to 175.00, marking a decrease of 80.00.
  • For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,039.56. It has decreased from 1,295.66 (Jun 24) to 1,039.56, marking a decrease of 256.10.
  • For PBDIT / Share (Rs.), as of Mar 25, the value is 279.85. This value is within the healthy range. It has decreased from 315.00 (Jun 24) to 279.85, marking a decrease of 35.15.
  • For PBIT / Share (Rs.), as of Mar 25, the value is 270.01. This value is within the healthy range. It has decreased from 297.59 (Jun 24) to 270.01, marking a decrease of 27.58.
  • For PBT / Share (Rs.), as of Mar 25, the value is 265.61. This value is within the healthy range. It has decreased from 289.34 (Jun 24) to 265.61, marking a decrease of 23.73.
  • For Net Profit / Share (Rs.), as of Mar 25, the value is 196.12. This value is within the healthy range. It has decreased from 207.95 (Jun 24) to 196.12, marking a decrease of 11.83.
  • For PBDIT Margin (%), as of Mar 25, the value is 26.92. This value is within the healthy range. It has increased from 24.31 (Jun 24) to 26.92, marking an increase of 2.61.
  • For PBIT Margin (%), as of Mar 25, the value is 25.97. This value exceeds the healthy maximum of 20. It has increased from 22.96 (Jun 24) to 25.97, marking an increase of 3.01.
  • For PBT Margin (%), as of Mar 25, the value is 25.54. This value is within the healthy range. It has increased from 22.33 (Jun 24) to 25.54, marking an increase of 3.21.
  • For Net Profit Margin (%), as of Mar 25, the value is 18.86. This value exceeds the healthy maximum of 10. It has increased from 16.05 (Jun 24) to 18.86, marking an increase of 2.81.
  • For Return on Networth / Equity (%), as of Mar 25, the value is 86.37. This value is within the healthy range. It has decreased from 87.11 (Jun 24) to 86.37, marking a decrease of 0.74.
  • For Return on Capital Employeed (%), as of Mar 25, the value is 102.66. This value is within the healthy range. It has decreased from 110.03 (Jun 24) to 102.66, marking a decrease of 7.37.
  • For Return On Assets (%), as of Mar 25, the value is 36.27. This value is within the healthy range. It has decreased from 36.31 (Jun 24) to 36.27, marking a decrease of 0.04.
  • For Asset Turnover Ratio (%), as of Mar 25, the value is 1.87. It has decreased from 2.11 (Jun 24) to 1.87, marking a decrease of 0.24.
  • For Current Ratio (X), as of Mar 25, the value is 1.23. This value is below the healthy minimum of 1.5. It has increased from 1.22 (Jun 24) to 1.23, marking an increase of 0.01.
  • For Quick Ratio (X), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 1. It has decreased from 0.99 (Jun 24) to 0.98, marking a decrease of 0.01.
  • For Inventory Turnover Ratio (X), as of Mar 25, the value is 15.10. This value exceeds the healthy maximum of 8. It has increased from 3.47 (Jun 24) to 15.10, marking an increase of 11.63.
  • For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 104.53. This value exceeds the healthy maximum of 50. It has decreased from 127.43 (Jun 24) to 104.53, marking a decrease of 22.90.
  • For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 99.53. This value exceeds the healthy maximum of 50. It has decreased from 117.59 (Jun 24) to 99.53, marking a decrease of 18.06.
  • For Earning Retention Ratio (%), as of Mar 25, the value is -4.53. This value is below the healthy minimum of 40. It has increased from -27.43 (Jun 24) to -4.53, marking an increase of 22.90.
  • For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.47. This value is below the healthy minimum of 40. It has increased from -17.59 (Jun 24) to 0.47, marking an increase of 18.06.
  • For Interest Coverage Ratio (X), as of Mar 25, the value is 63.52. This value is within the healthy range. It has increased from 38.18 (Jun 24) to 63.52, marking an increase of 25.34.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 45.52. This value is within the healthy range. It has increased from 26.21 (Jun 24) to 45.52, marking an increase of 19.31.
  • For Enterprise Value (Cr.), as of Mar 25, the value is 43,676.26. It has decreased from 53,361.78 (Jun 24) to 43,676.26, marking a decrease of 9,685.52.
  • For EV / Net Operating Revenue (X), as of Mar 25, the value is 12.94. This value exceeds the healthy maximum of 3. It has increased from 12.69 (Jun 24) to 12.94, marking an increase of 0.25.
  • For EV / EBITDA (X), as of Mar 25, the value is 48.08. This value exceeds the healthy maximum of 15. It has decreased from 52.19 (Jun 24) to 48.08, marking a decrease of 4.11.
  • For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 13.09. This value exceeds the healthy maximum of 3. It has increased from 12.83 (Jun 24) to 13.09, marking an increase of 0.26.
  • For Retention Ratios (%), as of Mar 25, the value is -4.53. This value is below the healthy minimum of 30. It has increased from -27.43 (Jun 24) to -4.53, marking an increase of 22.90.
  • For Price / BV (X), as of Mar 25, the value is 59.92. This value exceeds the healthy maximum of 3. It has decreased from 69.63 (Jun 24) to 59.92, marking a decrease of 9.71.
  • For Price / Net Operating Revenue (X), as of Mar 25, the value is 13.09. This value exceeds the healthy maximum of 3. It has increased from 12.83 (Jun 24) to 13.09, marking an increase of 0.26.
  • For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Jun 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Procter & Gamble Hygiene and Health Care Ltd as of February 22, 2026 is: ₹7,654.87

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of February 22, 2026, Procter & Gamble Hygiene and Health Care Ltd is Overvalued by 33.44% compared to the current share price ₹11,501.00

Intrinsic Value of Procter & Gamble Hygiene and Health Care Ltd as of February 22, 2026 is: ₹8,293.52

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of February 22, 2026, Procter & Gamble Hygiene and Health Care Ltd is Overvalued by 27.89% compared to the current share price ₹11,501.00

Last 5 Year EPS CAGR: 8.34%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 79.00%, which is a positive sign.
  2. The stock has a low average Working Capital Days of -17.08, which is a positive sign.
  3. The stock has a low average Cash Conversion Cycle of -94.92, which is a positive sign.
  4. The company has higher reserves (900.08 cr) compared to borrowings (1.46 cr), indicating strong financial stability.
  5. The company has shown consistent growth in sales (2.69 cr) and profit (642.54 cr) over the years.

    Stock Analysis

    • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Procter & Gamble Hygiene and Health Care Ltd:
      1. Net Profit Margin: 18.86%
        • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
      2. ROCE: 102.66% (Industry Average ROCE: 29.21%)
        • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
      3. ROE%: 86.37% (Industry Average ROE: 23.91%)
        • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
      4. Interest Coverage Ratio (Post Tax): 45.52
        • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
      5. Quick Ratio: 0.98
        • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
      6. Stock P/E: 43.4 (Industry average Stock P/E: 51.87)
        • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
      7. Total Debt / Equity: 0
        • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
      The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
      Stock Rating:

    About the Company - Qualitative Analysis

    Procter & Gamble Hygiene & Healthcare Ltd. is a Public Limited Listed company incorporated on 20/07/1964 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1964PLC012971 and registration number is 012971. Currently Company is involved in the business activities of Manufacture of wadding of textile materials and articles of wadding such as sanitary napkins and tampoons. Company's Total Operating Revenue is Rs. 3374.42 Cr. and Equity Capital is Rs. 32.46 Cr. for the Year ended 31/03/2025.
    INDUSTRYADDRESSCONTACT
    Personal CareP & G Plaza, Cardinal Gracias Road, Mumbai Maharashtra 400099Contact not found
    Management
    NamePosition Held
    Mr. Chittranjan DuaChairman & Ind.Director
    Mr. Kumar VenkatasubramanianManaging Director
    Mr. Ghanashyam HegdeExecutive Director
    Mr. Pramod AgarwalNon Executive Director
    Mr. Gagan SawhneyNon Executive Director
    Ms. Sonali DhawanNon Executive Director
    Mr. Krishnamurthy IyerIndependent Director
    Mr. Gurcharan DasIndependent Director
    Dr. Ashima GoyalIndependent Director

    FAQ

    What is the intrinsic value of Procter & Gamble Hygiene and Health Care Ltd?

    Procter & Gamble Hygiene and Health Care Ltd's intrinsic value (as of 21 February 2026) is ₹8293.52 which is 27.89% lower the current market price of ₹11,501.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹37,333 Cr. market cap, FY2025-2026 high/low of ₹14,543/11,312, reserves of ₹899 Cr, and liabilities of ₹2,133 Cr.

    What is the Market Cap of Procter & Gamble Hygiene and Health Care Ltd?

    The Market Cap of Procter & Gamble Hygiene and Health Care Ltd is 37,333 Cr..

    What is the current Stock Price of Procter & Gamble Hygiene and Health Care Ltd as on 21 February 2026?

    The current stock price of Procter & Gamble Hygiene and Health Care Ltd as on 21 February 2026 is ₹11,501.

    What is the High / Low of Procter & Gamble Hygiene and Health Care Ltd stocks in FY 2025-2026?

    In FY 2025-2026, the High / Low of Procter & Gamble Hygiene and Health Care Ltd stocks is ₹14,543/11,312.

    What is the Stock P/E of Procter & Gamble Hygiene and Health Care Ltd?

    The Stock P/E of Procter & Gamble Hygiene and Health Care Ltd is 43.4.

    What is the Book Value of Procter & Gamble Hygiene and Health Care Ltd?

    The Book Value of Procter & Gamble Hygiene and Health Care Ltd is 287.

    What is the Dividend Yield of Procter & Gamble Hygiene and Health Care Ltd?

    The Dividend Yield of Procter & Gamble Hygiene and Health Care Ltd is 1.48 %.

    What is the ROCE of Procter & Gamble Hygiene and Health Care Ltd?

    The ROCE of Procter & Gamble Hygiene and Health Care Ltd is 104 %.

    What is the ROE of Procter & Gamble Hygiene and Health Care Ltd?

    The ROE of Procter & Gamble Hygiene and Health Care Ltd is 75.7 %.

    What is the Face Value of Procter & Gamble Hygiene and Health Care Ltd?

    The Face Value of Procter & Gamble Hygiene and Health Care Ltd is 10.0.

    Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Procter & Gamble Hygiene and Health Care Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
    Explore Industry-wise Stock Analysis Reports